Meridian Investment Counsel Inc. Reduces Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Meridian Investment Counsel Inc. Reduces Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Meridian Investment Counsel Inc. reduced its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 3.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 35,358 shares of the pharmacy operator's stock after selling 1,293 shares during the period. Meridian Investment Counsel Inc.'s holdings in Walgreens Boots Alliance were worth $1,110,000 at the end of the most recent reporting period.
据HoldingsChannel.com报道，子午线投资顾问公司在第三季度减持了沃尔格林靴子联盟公司(纳斯达克代码：WBA-GET Rating)3.5%的股份。该机构投资者在此期间出售了1,293股后，持有这家药房运营商的35,358股股票。在最近一次报告期结束时，Meridian Investment Counsel Inc.在Walgreens Boots Alliance持有的股份价值111万美元。
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Advisors Asset Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 24.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 545,351 shares of the pharmacy operator's stock worth $17,124,000 after purchasing an additional 107,744 shares during the period. Todd Asset Management LLC boosted its stake in shares of Walgreens Boots Alliance by 5.5% during the 3rd quarter. Todd Asset Management LLC now owns 10,143 shares of the pharmacy operator's stock worth $318,000 after purchasing an additional 529 shares during the period. North Star Asset Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 16.9% during the 3rd quarter. North Star Asset Management Inc. now owns 11,757 shares of the pharmacy operator's stock worth $369,000 after purchasing an additional 1,699 shares during the period. Riverwater Partners LLC purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth about $251,000. Finally, Zions Bancorporation N.A. boosted its stake in shares of Walgreens Boots Alliance by 8.2% during the 3rd quarter. Zions Bancorporation N.A. now owns 83,201 shares of the pharmacy operator's stock worth $2,613,000 after purchasing an additional 6,321 shares during the period. 56.71% of the stock is owned by hedge funds and other institutional investors.
其他一些机构投资者和对冲基金也改变了他们在该业务中的头寸。Advisors Asset Management Inc.在第三季度增持了Walgreens Boots Alliance的股份24.6%。Advisors Asset Management Inc.在此期间又购买了107,744股，现在拥有545,351股这家药房运营商的股票，价值17,124,000美元。Todd Asset Management LLC在第三季度将其在Walgreens Boots Alliance的股份增加了5.5%。Todd Asset Management LLC在此期间额外购买了529股，现在拥有10,143股这家药房运营商的股票，价值31.8万美元。北极星资产管理公司在第三季度将其在Walgreens Boots Alliance的持股增加了16.9%。北极星资产管理公司现在持有这家药房运营商11,757股股票，价值36.9万美元，在此期间又购买了1,699股。Riverwater Partners LLC在第三季度购买了Walgreens Boots Alliance的新头寸，价值约251,000美元。最后，Zion Bancorporation N.A.在第三季度将其在Walgreens Boots Alliance的股份增加了8.2%。Zion Bancorporation N.A.在此期间又购买了6,321股，现在拥有83,201股这家药房运营商的股票，价值2,613,000美元。56.71%的股票由对冲基金和其他机构投资者持有。
Walgreens Boots Alliance Stock Down 1.6 %
沃尔格林靴子联盟股价下跌1.6%
WBA stock opened at $37.09 on Friday. The firm's fifty day simple moving average is $38.21 and its 200-day simple moving average is $37.18. The company has a market capitalization of $31.99 billion, a P/E ratio of -10.78, a price-to-earnings-growth ratio of 1.65 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.70 and a quick ratio of 0.36. Walgreens Boots Alliance, Inc. has a 12 month low of $30.39 and a 12 month high of $50.19.
WBA股票周五开盘报37.09美元。该公司的50日简单移动均线为38.21美元，200日简单移动均线为37.18美元。该公司市值为319.9亿美元，市盈率为-10.78，市盈率为1.65，贝塔系数为0.73。该公司的债务权益比为0.32，流动比率为0.70，速动比率为0.36。Walgreens Boots Alliance，Inc.的12个月低点为30.39美元，12个月高位为50.19美元。
Walgreens Boots Alliance Dividend Announcement
沃尔格林靴子联盟宣布分红
The company also recently declared a quarterly dividend, which will be paid on Friday, March 10th. Investors of record on Thursday, February 16th will be issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 5.18%. The ex-dividend date is Wednesday, February 15th. Walgreens Boots Alliance's dividend payout ratio (DPR) is presently -55.81%.
该公司最近还宣布了季度股息，将于3月10日(星期五)支付。2月16日(星期四)登记在册的投资者将获得每股0.48美元的股息。这意味着年化股息为1.92美元，收益率为5.18%。除息日为2月15日星期三。沃尔格林靴子联盟的股息支付率(DPR)目前为-55.81%。
Analyst Ratings Changes
分析师评级发生变化
A number of equities analysts recently commented on the stock. UBS Group lifted their price target on shares of Walgreens Boots Alliance to $40.00 in a research note on Monday, November 28th. Mizuho boosted their price objective on shares of Walgreens Boots Alliance from $36.00 to $41.00 and gave the company a "neutral" rating in a research report on Wednesday, December 14th. Cowen raised shares of Walgreens Boots Alliance from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $43.00 to $54.00 in a research report on Tuesday, November 22nd. Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $42.00 to $36.00 and set a "sector perform" rating for the company in a research report on Wednesday, October 19th. Finally, Credit Suisse Group lowered their price objective on shares of Walgreens Boots Alliance from $42.00 to $41.00 and set a "neutral" rating for the company in a research report on Friday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $43.31.
一些股票分析师最近对该股发表了评论。瑞银集团在11月28日星期一的一份研究报告中将沃尔格林靴子联盟的股票目标价上调至40.00美元。瑞穗在12月14日周三的一份研究报告中将沃尔格林靴子联盟的股票目标价从36.00美元上调至41.00美元，并给予该公司“中性”评级。在11月22日星期二的一份研究报告中，考恩将Walgreens Boots Alliance的股票评级从“市场表现”上调至“跑赢大盘”，并将该公司的目标价从43.00美元上调至54.00美元。10月19日，周三，加拿大皇家银行在一份研究报告中将沃尔格林靴子联盟的股票目标价从42.00美元下调至36.00美元，并为该公司设定了“行业表现”评级。最后，瑞士信贷集团在1月6日星期五的一份研究报告中将Walgreens Boots Alliance的股票目标价从42.00美元下调至41.00美元，并将该公司的评级定为“中性”。一位股票研究分析师对该公司股票的评级为卖出，十位分析师给出了持有评级，三位分析师给出了该公司股票的买入评级。根据MarketBeat的数据，该公司的平均评级为持有，共识目标价为43.31美元。
Insider Buying and Selling
内幕买卖
In related news, EVP Kevin M. Ban sold 10,303 shares of the stock in a transaction on Friday, November 18th. The shares were sold at an average price of $40.19, for a total transaction of $414,077.57. Following the sale, the executive vice president now directly owns 27,916 shares of the company's stock, valued at $1,121,944.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total transaction of $660,977.30. Following the sale, the director now directly owns 5,515 shares of the company's stock, valued at $219,993.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Kevin M. Ban sold 10,303 shares of the company's stock in a transaction on Friday, November 18th. The stock was sold at an average price of $40.19, for a total transaction of $414,077.57. Following the transaction, the executive vice president now owns 27,916 shares of the company's stock, valued at $1,121,944.04. The disclosure for this sale can be found here. 17.50% of the stock is currently owned by insiders.
在相关新闻中，执行副总裁凯文·M·潘在11月18日(星期五)的一次交易中出售了10,303股该股。这些股票的平均价格为40.19美元，总成交额为414,077.57美元。出售后，执行副总裁总裁现在直接持有该公司27,916股股票，价值1,121,944.04美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过这个环节。在相关新闻中，董事南希·M·斯克里希廷在11月17日(星期四)的一次交易中出售了16,570股该股。这些股票以39.89美元的平均价格出售，总成交额为660,977.30美元。交易完成后，董事现在直接持有5515股阿里巴巴股票，价值21.993.35美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可通过这个环节。此外，执行副总裁凯文·M·潘在11月18日星期五的一次交易中出售了10,303股公司股票。该股以40.19美元的平均价格出售，总成交金额为414,077.57美元。交易完成后，执行副总裁总裁现在持有该公司27,916股股票，价值1121,944.04美元。关于这次销售的披露可以找到这里。该公司17.50%的股份目前由内部人士持有。
About Walgreens Boots Alliance
关于沃尔格林靴子联盟
(Get Rating)
(获取评级)
Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.
沃尔格林靴子联盟公司从事医疗保健和零售药房服务的提供。它通过以下部门运作：美国零售药房、国际和美国医疗保健。美国零售药房部门包括零售药店的运营、健康和保健服务、专业和送货上门的药房服务，以及股权法投资。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- 免费获取StockNews.com关于沃尔格林靴子联盟(WBA)的研究报告
- 市场回顾周-1/30-2/3
- 细价股值得吗？你应该投资细价股吗？
- Zimmer Biomet盈利节节攀升，增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
- 福特股票在盈利大幅下滑后继续前进
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating).
想看看其他对冲基金持有哪些WBA吗？访问HoldingsChannel.com获取沃尔格林靴子联盟公司(纳斯达克：wba-Get Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.
接受沃尔格林靴子联盟每日的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Walgreens Boots Alliance和相关公司的最新新闻和分析师评级的每日简要摘要。